New catheter aims to tame stubborn AFib
NCT ID NCT07321002
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new shape-adaptive catheter that uses pulsed field ablation to treat persistent atrial fibrillation (AFib), a type of irregular heartbeat. 35 adults with persistent AFib will receive the procedure under general anesthesia. Researchers will check for serious side effects within 7 days and see if the treatment successfully restores normal heart rhythm.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PFLotus catheter and DePolar mapping system
What this could lead to
If successful, this could provide a safer and more effective way to treat persistent atrial fibrillation using a single catheter system.
What could go wrong
This is a small, early-stage trial with only 35 participants. The procedure carries risks like bleeding, heart damage, or irregular heartbeat. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••